Skip to main content

Advertisement

SpringerLink
Log in

Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Myofascial pain syndrome is a chronic muscle pain disorder in one or more muscles or groups of muscles accompanied by local and referred pain, decreased range of motion, weakness, and often autonomic phenomena. Patients are readily recognized by their history of muscle pain and the presence of myofascial trigger points, which are specific areas of hyperirritability in a muscle that cause local and referred pain on palpation. Failure to recognize MPS often leads to over-investigation, unnecessary medical intervention, and iatrogenic harm with serious cost implications. The purpose of this review is to present clinically relevant data regarding myofascial pain syndrome and to discuss its possible role in the pathophysiology and optimal treatment of fibromyalgia syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rachlin ES: Myofascial pain and fibromyalgia. St. Louis: Mosby;1994:3–29, 145–195.

    Google Scholar 

  2. Gerwin RD: Differential diagnosis of myofascial pain syndrome and fibromyalgia. J Musculoske Pain 1999, 7(1/2):209–215.

    Article  Google Scholar 

  3. Travell JG, Simons DG, Simons LS: Myofascial pain and dysfunction: The triggerpoint manual. edn 2 (1). Baltimore:Williams & Wilkins; 1999.The major comprehensive text on the clinical evaluation and management of myofascial pain syndromes. An overview of recent findings regarding the pathophysiology of myofascial trigger points is included.

    Google Scholar 

  4. Long SP, Kephart W: Myofascial pain syndrome. In The Management of Pain. Edited by Ashburn MA, Rice LJ.Philadelphia: Churchill Livingstone; 1998:299–321.

    Google Scholar 

  5. Han SC, Harrison P: Myofascial pain syndrome and triggerpoint management. Reg Anesth 1997, 22(1):89–101.

    Article  PubMed  CAS  Google Scholar 

  6. Chu J: Twitch response in myofascial trigger points. J Musculoske Pain 1998, 6(4):99–116.

    Google Scholar 

  7. Gerwin RD: Myofascial pain syndromes in the upper extremity. J Hand Ther 1997, 10:130–136.

    PubMed  CAS  Google Scholar 

  8. Fricton JR: Myofascial pain. Baillière’s Clin Rheum 1994, 8(4):857–880.

    Article  CAS  Google Scholar 

  9. Skootsky SA, Jaeger B, Oye RK: Prevalence of myofascial pain in general internal medicine practice. West J Med 1989, 151:157–160.

    PubMed  CAS  Google Scholar 

  10. Schiffman EL, Fricton JR, Haly DP, Shapiro BL: The prevalence and treatment needs of subjects with temporomandibular disorder. JADA 1990, 120:295–303.

    PubMed  CAS  Google Scholar 

  11. Gerwin RD: A study of 96 subjects examined both for fibromyalgia and myofascial pain [Abstract]. J Musculoske Pain 1995, 3(suppl 1):21.

    Google Scholar 

  12. Collée BA, Dijkmans AC, van den Broucke JP, et al.: A clinical epidemiological study in low back pain: description of two clinical syndromes. Brit J Rheum 1990, 29:354–357.

    Article  Google Scholar 

  13. Rosomoff HL, Rosomoff RS: Low back pain: evaluation and management in the primary care setting. Med Clin North Am 1999, 3:643–662.This article illustrates that assessment for the presence of myofascial pain syndrome and myofascial triggerpoints in the clinical evaluation of a patient with low back pain is mandatory. This syndrome often can be treated with a high degree of success.

    Article  Google Scholar 

  14. Cherkin DC, Devo RA, Wheeler K, Ciol MA: Physician variation in diagnostic testing for low back pain: who you see is what you get. Arthr Rheum 1994, 37:15–22.

    Article  CAS  Google Scholar 

  15. Boden SD, Davis DO, Dina TS, et al.: Abnormal magneticresonance scans of the lumbar spine in asymptomatic subjects. J Bone Joint Surg Am 1990, 72:403–408.

    PubMed  CAS  Google Scholar 

  16. Rosomoff HL, Fishbain DA, Goldberg M, et al.: Physical findings in patients with chronic intractable benign pain of the neck and/or back. Pain 1989, 37:279–287.

    Article  PubMed  CAS  Google Scholar 

  17. Davidoff RA: Trigger points and myofascial pain: towards understanding how they affect headaches. Cephalalgia 1998, 18:436–448.

    Article  PubMed  CAS  Google Scholar 

  18. Gerwin R: Are myofascial trigger points related to chronic mixed tension type/migrainous headaches? [Abstract]. J Musculoske Pain 2001, 9(Suppl 5):84.

    Google Scholar 

  19. G:obel H, Heinze A, Heinze-Kuhn K, Austerman K: Botulunim toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001, 91:195–199.

    Article  CAS  Google Scholar 

  20. Pawl RP: Chronic neck syndromes: an update. Comp Ther 1999, 25(5):278–282.

    CAS  Google Scholar 

  21. Buskila D, Neumann L, Vaisberg G, et al.: Increased rates of fibromyalgia following cervical spine injury. Arthritis Rheumatism 1997, 40(3):446–452.

    Article  PubMed  CAS  Google Scholar 

  22. Granges G, Littlejohn G: Prevalence of myofascial pain syndrome in fibromyalgia syndrome and regional pain syndrome: a comparative study. J Musculosk Pain 1993, 1(2):19–35.

    Article  Google Scholar 

  23. Allen G, Galer BS, Schwartz L: Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain 1998, 80:539–544.

    Article  Google Scholar 

  24. Rashiq S, Galer BS: Proximal myofascial dysfunction in complex regional pain syndrome: a retrospective prevalence study. Clin J Pain 1999, 15:151–153.

    Article  PubMed  CAS  Google Scholar 

  25. Simons DG: Clinical and etiological update of myofascial pain from trigger points. J Musculoske Pain 1996, 4(1/2):93–121.

    Article  Google Scholar 

  26. Gerwin RD, Shannon S, Hong CZ, et al.: Interrator reliability in myofascial triggerpoint examination. Pain 1997, 69:65–73.

    Article  PubMed  CAS  Google Scholar 

  27. Russel J: Reliability of clinical assessment measures for the classification of myofascial pain syndrome. J Musculoske Pain 1999, 7(112):309–324.

    Article  Google Scholar 

  28. Simons D: Muscular pain syndromes. In Advances in Pain Research and Therapy. Vol 17. Edited by Friction JR, Awad EA.Philadelphia: Lippincott-Raven; 1990.

    Google Scholar 

  29. Graff-Radford SB: Regional myofascial pain syndrome and headache: Principles of diagnosis and management. Curr Pain Headache Rep 2001, 5:376–381.This article reviews the concept of myofascial pain syndrome as a frequent cause of headache. This systematic approach studied 25 consecutive patients with myofascial headache and had an excellent outcome.

    Article  PubMed  CAS  Google Scholar 

  30. Gerwin RD, Duranleau D: Ultrasound identification of the myofascial trigger point [Letter]. Muscle Nerve 1997, 20:767–768.

    PubMed  CAS  Google Scholar 

  31. Baldry PE: Myofascial pain and fibromyalgia syndromes: a clinical guide to diagnosis and management. London: Churchill Livingstone; 2001.

    Google Scholar 

  32. Gerwin RD: Neurobiology of the myofascial trigger point. Baill Clin Rheum 1994, 8(4):747–762.

    Article  CAS  Google Scholar 

  33. Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994, 59:65–69.

    Article  PubMed  CAS  Google Scholar 

  34. Aronoff GM: Myofascial pain and fibromyalgia: a critical assessment and alternate view. Clin J Pain 1998, 14(1):74–85.

    Article  PubMed  CAS  Google Scholar 

  35. Simons DG: Diagnostic criteria of myofascial pain caused by trigger points. J Musculoske Pain 1999, 7(112):111–120.

    Article  Google Scholar 

  36. Simons DG, Hong C, Simons LS: Prevalence of spontaneous electrical activity at trigger spots and at control sites in rabbit skeletal muscle. J Musculoske Pain 1995, 3(1):35–48.

    Article  Google Scholar 

  37. Bennett RM: The origin of myopain: an integrated hypothesis of focal muscle changes and sleep disturbance in patients with the fibromyalgia syndrome. J Musculoske Pain 1993, 1:95–112.

    Article  Google Scholar 

  38. Simons DB: Myofascial pain syndrome due to triggerpoints. In Rehabilitation Medicine. Edited by Goodgold J. St Louis:Mosby; 1988:686–723.

    Google Scholar 

  39. Simons DG, Hong C-Z, Simons LS: Spontaneous electrical activity of trigger points [Abstract]. J Musculoskel Pain 1995, 3(Suppl 1):124.

    Google Scholar 

  40. McNulty W, Gevirtz R, Berkoff G, Hubbard D: Needle electromyographic evaluation of trigger point response to a psychological stressor. Psychophysiology 1994, 31:313–316.

    Article  PubMed  CAS  Google Scholar 

  41. Hong C-Z, Simons DG: Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil 1998, 79:863–872.

    Article  PubMed  CAS  Google Scholar 

  42. Simons DG: Neurophysiological basis of pain caused by trigger points. Amer Pain Soc J 1994, 3:17–19.

    Google Scholar 

  43. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993, 54:241–289.

    Article  PubMed  CAS  Google Scholar 

  44. Mense S: Referral of muscle pain: new aspects. Amer Pain Soc J 1994, 3:1–9.

    Google Scholar 

  45. Hong CZ: Pathophysiology of myofascial trigger point. J Formos Med Assoc 1996, 95(2):93–103.

    PubMed  CAS  Google Scholar 

  46. Wolfe F, Simons D, Fricton J, et al.: The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome, and no disease. J Rheumatol 1992, 19:944–951.

    PubMed  CAS  Google Scholar 

  47. Borg-Stein J, Stein J: Trigger points and tender points: one and the same? Does injection treatment help? Rheum Dis Clin North Am 1996, 22(2):305–322.

    Article  PubMed  CAS  Google Scholar 

  48. Inanici F, Yunus MB, Aldag JC: Clinical features and psychologic factors in regional soft tissue pain: comparison with fibromyalgia syndrome. J Musculoske Pain 1999, 7(1/2):293–301.

    Article  Google Scholar 

  49. Coderre TJ, Katz J, Vaccarino AL, Melzack R: Contribution of central neuroplasticity to pathological pain: a review of clinical and experimental evidence. Pain 1993, 52:259–285.

    Article  PubMed  CAS  Google Scholar 

  50. Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in Fibromyalgia. Mayo Clin Proc 1999, 74:385–398.A masterly review with 180 references on the neurobiology of central sensitization and chronic pain. The article illustrates how nociceptive afferent input acts as a potent inducer of central sensitization with numerous clinical applications.

    Article  PubMed  CAS  Google Scholar 

  51. Buskila D, Neumann L: Fibromyalgia syndrome and non-articular tenderness in relatives of patients with FMS. J Rheumatol 1997, 24:941–944.

    PubMed  CAS  Google Scholar 

  52. Mense S: Neurobiological concepts of fibromyalgia: the possible role of descending spinal tracts. Scand J Rheumatol 2000, 29(Suppl 113):24–29.

    Article  Google Scholar 

  53. Martinez-Lavin M: Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol 2001, 19:1–3.

    PubMed  CAS  Google Scholar 

  54. Hassett AL, Cone JD, Patella SJ, Sigal LH: The role of catastrophizing in the pain and depression of women with FMS. Arthr Rheum 2000, 43(11):2493–2500.

    Article  CAS  Google Scholar 

  55. Ferrari R: The biopsychosocial model: a tool for rheumatologists. Baill Clin Rheum 2000, 14(4):787–195.This review illustrates the limitations of the reductionistic dualistic biomedical model in the assessment and management of patients with FMS and MPS. A more holistic, patient-centered biopsychosocial approach is needed.

    Article  CAS  Google Scholar 

  56. Ploghaus A, Tracey I, Gati JS, et al.: Dissociating pain from its anticipation in the human brain. Science 1999, 284:1979–1981.

    Article  PubMed  CAS  Google Scholar 

  57. Asburn MA, Staats PS: Pain: Management of chronic pain. Lancet 1999, 353:1865–1869.

    Article  Google Scholar 

  58. Brumberg LR, Fischer AA, Barber JM, et al.: Triggerpoint injection technique to induce prolonged pain relief [Abstract]. Phys Med Rehabil 1997, 78:1042.

    Google Scholar 

  59. Carlson CR, Okeson JP, Falace DA, et al.: Reduction of pain and EMG activity in the masseter region by trapezius triggerpoint injection. Pain 1993, 55:397–400.

    Article  PubMed  CAS  Google Scholar 

  60. Hong CZ: Lidocaine injection versus dry needling to myofascial triggerpoint: the importance of the local twitch response. Am J Phys Med Rehabil 1994, 73:256–263.

    Article  PubMed  CAS  Google Scholar 

  61. Jaeger B, Skootsky SA: Double blind conrolled study of different myofascial triggerpoint injection techniques. Pain 1987, 4(suppl):560.

    Google Scholar 

  62. Bennett RM: Fibromyalgia: the commonest cause of widespread pain. Comp Ther 1995, 21(6):269–275.

    CAS  Google Scholar 

  63. Fine PG, Milano R, Hare BD: The effects of trigger point injections are naloxone reversible. Pain 1988, 32:15–20.

    Article  PubMed  CAS  Google Scholar 

  64. Fischer AA: Trigger point injections can be performed pain free using preinjection block (PIB). J Musculoske Pain 1995, 3(Suppl 1):140.

    Google Scholar 

  65. Reddy SS, Yunus MB, Inanici F, Aldag JC: Tender point injections are beneficial in Fibromyalgia syndrome: a descriptive open study. J Musculoske Pain 2000, 8(4):7–20.

    Article  Google Scholar 

  66. Porta M: A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome. Pain 2000, 85:101–105.

    Article  PubMed  CAS  Google Scholar 

  67. Yue SK: Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunctions. J Musculoske Pain 1995, 3(Suppl 1):22.

    Google Scholar 

  68. Bowsher D. Mechanisms of acupuncture. In Medical acupuncture: A Western Scientific Approach. Edited by Filshie J,White A. Edinburgh: Churchill Livingstone; 1998.

    Google Scholar 

  69. Graff-Radford SB, Reeves JL, Baker RL, Chiu D: Effects of transcutaneous electrical nerve stimulation on myofascial pain and trigger point sensitivity. Pain 1989, 37:1–5.

    Article  PubMed  CAS  Google Scholar 

  70. Melzack R, Wall PD: Pain mechanisms: new theory. Science 1965, 150:971–979.

    Article  PubMed  CAS  Google Scholar 

  71. Yunus MB: Research in fibromyalgia and myofascial pain syndromes: current status, problems and future directions. J of Muskuloske Pain 1993, 1(1):23–41.

    Article  Google Scholar 

  72. Smythe H: Links between fibromyalgia and myofascial pain syndromes. J Rheum 1992, 19(6):842–843.

    PubMed  CAS  Google Scholar 

  73. Portenoy RK: Opoid therapy for chronic non-malignant pain: a review of critical issues. J Pain Symptom Manage 1996, 11:203–217.

    Article  PubMed  CAS  Google Scholar 

  74. Shipton EA: Tramadol: present and future. Anaesth Intensive Care 2000, 28:363–374.

    PubMed  CAS  Google Scholar 

  75. Duthi DJR: Remifentanil and tramadol. Br J Anaesth 1998, 81:51–57.

    Google Scholar 

  76. Biasi G, Manca S, Manganelli S, Marcolongo R: Tramadol in the fibromyalgia syndrome: A controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998, 18:13–19.

    PubMed  CAS  Google Scholar 

  77. Bennett RM: A blinded, placebo-controlled evaluation of tramadol in the management of fibromyalgia pain [Abstract]. J Musculoske Pain 1998, 6(Suppl 2):146.

    Google Scholar 

  78. Jaeschke R, Adachi J, Guyatt G, et al.: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N of 1 randomized controlled trials. J Rheumatol 1991, 18:447–451.

    PubMed  CAS  Google Scholar 

  79. Sharav Y, Singer E, Schmidt E, et al.: The analgesic effect of amitriptyline on severe facial pain. Pain 1987, 31:199–203.

    Article  PubMed  CAS  Google Scholar 

  80. Woolf CJ, Mannion RJ: Neuropathic pain: etiology, symptoms, mechanisms and management. Lancet 1999, 353:1959–1964.

    Article  PubMed  CAS  Google Scholar 

  81. Greeff OBW: The different modes of action of benzodiazepine and non-benzodiazepine hypnotics: a review of clinical benefits. Geneeskunde - the medicine journal 2001, 43(8):8–11.

    Google Scholar 

  82. Yunus MB: Research in fibromyalgia and myofascial pain syndromes: current status, problems and future directions. J Musculoske Pain 1993, 1(1):23–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Of Pretoria, Private Bag X 396, 0001, Pretoria, South Africa

    Helgard P. Meyer MBCLB & Mprax Med MFGP(SA)

Authors
  1. Helgard P. Meyer MBCLB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mprax Med MFGP(SA)
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, H.P., Med, M. Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome. Current Science Inc 6, 274–283 (2002). https://doi.org/10.1007/s11916-002-0048-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-002-0048-z

Keywords

Search

Navigation